4.7 Review

DNA polymerases and cancer

Journal

NATURE REVIEWS CANCER
Volume 11, Issue 2, Pages 96-110

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2998

Keywords

-

Categories

Funding

  1. National Cancer Institute [CA09717, CA132840]
  2. National Institute of Environmental Health Sciences [P30ES007784]
  3. NIH Cancer Center (University of Texas MD Anderson Cancer Center, USA) [P30-CA016672]

Ask authors/readers for more resources

There are 15 different DNA polymerases encoded in mammalian genomes, which are specialized for replication, repair or the tolerance of DNA damage. New evidence is emerging for lesion-specific and tissue-specific functions of DNA polymerases. Many point mutations that occur in cancer cells arise from the error-generating activities of DNA polymerases. However, the ability of some of these enzymes to bypass DNA damage may actually defend against chromosome instability in cells, and at least one DNA polymerase, Pol zeta, is a suppressor of spontaneous tumorigenesis. Because DNA polymerases can help cancer cells tolerate DNA damage, some of these enzymes might be viable targets for therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available